CX-01 Combined With Azacitidine in the Treatment of Relapsed or Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia
Clinical trial NCT02995655 · COMPLETED
Trial details
- NCT number
- NCT02995655
- Sponsor
- Washington University School of Medicine
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-07
- Primary completion
- 2018-09-13
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.